<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03898869</url>
  </required_header>
  <id_info>
    <org_study_id>BTK-01</org_study_id>
    <nct_id>NCT03898869</nct_id>
  </id_info>
  <brief_title>Measurement of Revascularization Effect Using NIRS in BTK Arteries</brief_title>
  <official_title>Measurement of Revascularization Effect Using Near Infrared Spectroscopy in Below the Knee Arteries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vilnius University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vilnius University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient with occluded below the knee arteries and chronic limb ischemia Rutherford class V-VI
      are enrolled.

      During endovascular recanalisation procedure changes in tissue oxygen amount is recorded
      using near infrared spectroscopy (NIRS).

      Primary hypothesis - NIRS can be used to determine sufficient amount of blood reaching the
      ulcered ishemic area.

      Secondary hypothesis - NIRS can be useful in detecting early recoil after BTK recanalisation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2019</start_date>
  <completion_date type="Anticipated">January 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Increase in oxygen amount sufficient for wound healing</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Detection of early recoil after BTK revascularization</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Percutaneous Transluminal Angioplasty</condition>
  <condition>Wound Heal</condition>
  <condition>Ischemic Feet</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Intraoperative NIRS monitoring</intervention_name>
    <description>Near infrared spectroscopy non invasively used to register changes in tissue oxygen amount during endovascular revascularization</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All-comers meeting eligibility criteria in VMK hospital, Vascular surgery department.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Critical limb ischemia Rutherford V-VI

          -  At least one artery below the knee is planned to revascularize

        Exclusion Criteria:

          -  Blood oxygen saturation below 85% because of any comorbidities

          -  Life expectancy less than 12 months

          -  Unavoidable amputation above ankle

          -  Skin diseases preventing the use of NIRS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomas Baltrūnas</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vilnius University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tomas Baltrūnas</last_name>
    <phone>+37052344519</phone>
    <email>tomas.baltrunas@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Vilniaus Miesto Klinikinė hospital</name>
      <address>
        <city>Vilnius</city>
        <zip>LT-10207</zip>
        <country>Lithuania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomas Baltrūnas</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Lithuania</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 29, 2019</study_first_submitted>
  <study_first_submitted_qc>March 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2019</study_first_posted>
  <last_update_submitted>March 29, 2019</last_update_submitted>
  <last_update_submitted_qc>March 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vilnius University</investigator_affiliation>
    <investigator_full_name>Tomas Baltrūnas</investigator_full_name>
    <investigator_title>Tomas Baltrūnas</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

